Welcome to our dedicated page for Omega Flex SEC filings (Ticker: OFLX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Omega Flex's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Omega Flex's regulatory disclosures and financial reporting.
Omega Flex, Inc. Chief Executive Officer Dean W. Rivest bought 1,000 shares of common stock in an open-market transaction at $29.50 per share. This increases his directly held stake to 1,000 shares.
He also has an indirect holding of 2,487 equivalent shares in the company stock fund within the issuer’s 401(k) plan, based on a statement dated 12/31/2025.
Omega Flex, Inc. reported softer 2025 results as demand in construction-related markets eased. Net sales were $98.3M, down 3.3% from $101.7M in 2024, mainly from lower unit volumes tied to weaker housing starts.
Despite the sales decline, gross margin remained high at 60.0%, versus 61.2% a year earlier, but higher selling, administrative and engineering costs compressed profitability. Operating profit fell 21.5% to $16.9M. Net income still added to retained earnings, which reached $74.0M as of December 31, 2025.
Cash and cash equivalents increased to $53.2M, supported by $17.2M of operating cash flow, while capital spending was modest at $1.8M. The company paid $13.7M in dividends and continues to emphasize its core flexible metal hose lines, particularly TracPipe® and CounterStrike® CSST, which drive most sales.
Omega Flex, Inc. reported lower sales and earnings for 2025 and the fourth quarter of 2025. Full-year net sales were $98,296,000 versus $101,681,000 in 2024, a 3.3% decline mainly from lower unit volumes as housing starts weakened.
Full-year net income fell to $14,827,000 from $18,014,000, down 17.7%, with management citing both lower sales and higher product development, certification and consulting expenses. Earnings per share decreased from $1.78 to $1.47. In the fourth quarter, net sales and net income declined 6.5% and 27.1%, respectively, compared with the prior-year period.
Omega Flex Vice President and CFO Matthew Francis Unger reported a set of transactions involving phantom stock and common shares. He exercised 395 units of phantom stock, each economically equivalent to one share of common stock and settled on a one-for-one basis. This exercise corresponded to 395 shares of common stock at a stated price of $0.0000 per share. On the same date, he disposed of 395 shares of common stock to the issuer at $37.55 per share, resulting in 0 shares of common stock held directly after these transactions.
Omega Flex, Inc. President and director Edwin B. Moran reported several transactions involving 494 units of phantom stock and 494 shares of common stock on February 22, 2026. He exercised 494 units of phantom stock, each economically equivalent to one share and settled for cash on a one-for-one basis, into 494 shares of common stock at $0.00 per share. Those 494 common shares were then disposed of back to the issuer at $37.55 per share, leaving no directly held shares from this block. Separately, an equivalent of 405 common shares is reported as held indirectly through the company’s 401(k) plan based on a December 31, 2025 statement.
Omega Flex, Inc. chief executive officer Dean W. Rivest reported several transactions involving company-related equity on February 22, 2026. He exercised 593 units of Phantom Stock, which are economically equivalent to common shares and are settled for cash on a one-for-one basis, into 593 shares of common stock at $0.00 per share. He then disposed of 593 common shares back to the issuer at $37.55 per share in a transaction coded as a disposition to the issuer. Separately, an equivalent of 2,487 common shares is held indirectly in the company stock fund within the issuer's 401(k) plan, based on a statement as of December 31, 2025.
Omega Flex, Inc. reported that VP, General Counsel and Secretary Susan B. Asch acquired 820 units of phantom stock in a grant classified as a derivative award. The units were granted at a price of $0.00 per unit and increased her direct holdings of phantom stock to 820 units.
Each unit of phantom stock is the economic equivalent of one share of Omega Flex common stock, giving her compensation tied to the company’s share value without issuing actual shares.
Omega Flex, Inc. reported that its Vice President and CFO, Matthew Francis Unger, acquired 1,641 units of phantom stock through a grant or award. Each phantom stock unit is the economic equivalent of one share of Omega Flex common stock, giving him 1,641 units outstanding after this transaction.
Moran Edwin B. reported acquisition or exercise transactions in this Form 4 filing.
Omega Flex, Inc. reported that President and director Edwin B. Moran received a grant of 2,051 units of phantom stock on February 18, 2026. The award was made at a price of $0.00 per unit as a form of compensation. Each unit of phantom stock is the economic equivalent of one share of Omega Flex common stock, giving Moran 2,051 phantom stock units following the transaction.
Omega Flex, Inc. reported that Chief Executive Officer and director Rivest Dean W. acquired 2,461 units of phantom stock, each economically equivalent to one share of Omega Flex common stock. The units were granted at a stated price of $0.00 per unit as compensation.
The filing also records amendments to this phantom stock award, changing both the date exercisable and the expiration date from 02/18/2026 to 02/18/2030. After this grant, the CEO held 2,461 phantom stock units directly.